Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Chen, Hung Yuan ^a,b   Chiu, Yen Ling ^a,b   Chuang, Yi Fang ^c   Hsu, Shih Ping ^a,b   Pai, Mei Fen ^a,b   Yang, Ju Yeh ^a,b   Peng, Yu Sen ^a,b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Abdominal obesity; Cardiovascular complication; Survival; Visceral adiposity index

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; VISCERAL ADIPOSITY INDEX; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO; AGED; BODY MASS; CARDIOVASCULAR DISEASES; COMPLICATION; INTRAABDOMINAL FAT; MIDDLE AGED; MORTALITY; OBESITY; PHYSIOLOGY; PREVALENCE; PROCEDURES; RENAL REPLACEMENT THERAPY; RISK; VERY ELDERLY;

ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK;

EID: 84907630687     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0136-5     Document Type: Article

References (40)

1. DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, Poehlman ET. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001, 24(5):925-932. 10.2337/diacare.24.5.925, 11347756.
2. Chen HY, Lin CC, Chiu YL, Hsu SP, Pai MF, Yang JY, Peng YS. Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PLoS One 2012, 7(7):e38415. 10.1371/journal.pone.0038415, 22815691.
3. Cordeiro AC, Qureshi AR, Stenvinkel P, Heimburger O, Axelsson J, Barany P, Lindholm B, Carrero JJ. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 2010, 25(2):562-568. 10.1093/ndt/gfp492, 19762603.
4. Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK, de Lemos JA. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012, 308(11):1150-1159. 10.1001/2012.jama.11132, 22990274.
5. Kato A, Ishida J, Endo Y, Takita T, Furuhashi M, Maruyama Y, Odamaki M. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant 2011, 26(6):1967-1976. 10.1093/ndt/gfq652, 20980356.
6. Honda H, Qureshi AR, Axelsson J, Heimburger O, Suliman ME, Barany P, Stenvinkel P, Lindholm B. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007, 86(3):633-638. 17823427.
7. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KG, Tjonneland A, Halkjaer J, Jensen MK, Stegger J, Clavel-Chapelon F, Boutron-Ruault MC, Chajes V, Linseisen J, Kaaks R, Trichopoulou A, Trichopoulos D, Bamia C, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Peeters PH, May AM, Bueno-de-Mesquita HB, van Duijnhoven FJ, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008, 359(20):2105-2120. 10.1056/NEJMoa0801891, 19005195.
8. Zoccali C, Torino C, Tripepi G, Mallamaci F. Assessment of obesity in chronic kidney disease: what is the best measure?. Curr Opin Nephrol Hypertens 2012, 21(6):641-646. 10.1097/MNH.0b013e328358a02b, 23010758.
9. Evans PD, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS One 2012, 7(4):e34699. 10.1371/journal.pone.0034699, 22511960.
10. Postorino M, Marino C, Tripepi G, Zoccali C, Group CW. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009, 53(15):1265-1272. 10.1016/j.jacc.2008.12.040, 19358939.
11. Sanches FM, Avesani CM, Kamimura MA, Lemos MM, Axelsson J, Vasselai P, Draibe SA, Cuppari L. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 2008, 52(1):66-73. 10.1053/j.ajkd.2008.02.004, 18440683.
12. Taylor AE, Ebrahim S, Ben-Shlomo Y, Martin RM, Whincup PH, Yarnell JW, Wannamethee SG, Lawlor DA. Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr 2010, 91(3):547-556. 10.3945/ajcn.2009.28757, 20089729.
13. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 1998, 67(1):44-49. 9440374.
14. Lamacchia O, Pinnelli S, Camarchio D, Fariello S, Gesualdo L, Stallone G, Cignarelli M. Waist-to-height ratio is the best anthropometric index in association with adverse cardiorenal outcomes in type 2 diabetes mellitus patients. Am J Nephrol 2009, 29(6):615-619. 10.1159/000194454, 19151548.
15. Postorino M, Marino C, Tripepi G, Zoccali C, Group CW. Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients. Kidney Int 2011, 79(7):765-772. 10.1038/ki.2010.493, 21178980.
16. Zoccali C, Postorino M, Marino C, Pizzini P, Cutrupi S, Tripepi G, Group CW. Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. J Intern Med 2011, 269(2):172-181. 10.1111/j.1365-2796.2010.02288.x, 21138492.
17. Lin HH, Lee JK, Yang CY, Lien YC, Huang JW, Wu CK. Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis. Cardiovasc Diabetol 2013, 12:127. 10.1186/1475-2840-12-127, 24001037.
18. Pellicano R, Strauss BJ, Polkinghorne KR, Kerr PG. Longitudinal body composition changes due to dialysis. Clin J Am Soc Nephrol 2011, 6(7):1668-1675. 10.2215/CJN.06790810, 21734086.
19. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, AlkaMeSy Study G. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010, 33(4):920-922. 10.2337/dc09-1825, 20067971.
20. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Charalampidis P, Livadas S, Kollias A, Sabico SL, Chrousos GP. Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur J Clin Investig 2013, 43(2):183-189. 10.1111/eci.12030.
21. Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 2011, 10:183. 10.1186/1476-511X-10-183, 22011564.
22. Mohammadreza B, Farzad H, Davoud K, Fereidoun AF. Prognostic significance of the complex " Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc Diabetol 2012, 11:20. 10.1186/1475-2840-11-20, 22394430.
23. Chen HY, Chiu YL, Chuang YF, Hsu SP, Pai MF, Lai CF, Yang JY, Peng YS, Tsai TJ, Wu KD. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. Am J Kidney Dis 2010, 56(4):720-727. 10.1053/j.ajkd.2010.06.015, 20801568.
24. Chiu YL, Chen HY, Chuang YF, Hsu SP, Lai CF, Pai MF, Yang SY, Peng YS. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant 2008, 23(11):3685-3689. 10.1093/ndt/gfn303, 18515654.
25. Chen HY, Chiu YL, Hsu SP, Pai MF, Lai CF, Peng YS, Kao TW, Hung KY, Tsai TJ, Wu KD. Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol 2009, 160(5):777-783. 10.1530/EJE-08-0813, 19228823.
26. Chen HY, Chiu YL, Hsu SP, Pai MF, Lai CF, Yang JY, Peng YS, Tsai TJ, Wu KD. Elevated C-reactive protein level in hemodialysis patients with moderate/severe uremic pruritus: a potential mediator of high overall mortality. QJM 2010, 103(11):837-846. 10.1093/qjmed/hcq036, 20350963.
27. Lai CF, Liao CH, Pai MF, Chu FY, Hsu SP, Chen HY, Yang JY, Chiu YL, Peng YS, Chang SC, Hung KY, Tsai TJ, Wu KD. Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Clin J Am Soc Nephrol 2011, 6(1):167-174. 10.2215/CJN.06270710, 20947786.
28. Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S, Kumagai H. Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 2008, 87(1):106-113. 18175743.
29. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005, 81(3):543-554. 15755821.
30. Miyamoto T, Rashid Qureshi A, Heimburger O, Barany P, Carrero K, Sjoberg B, Lindholm B, Stenvinkel P, Carrero JJ. Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease. Clin J Am Soc Nephrol 2011, 6(12):2785-2791. 10.2215/CJN.02320311, 22157708.
31. Carvalho LK, Barreto Silva MI, da Silva Vale B, Bregman R, Martucci RB, Carrero JJ, Avesani CM. Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients Stages 3 and 4: a longitudinal study. Nephrol Dial Transplant 2012, 27(4):1423-1428. 10.1093/ndt/gfr450, 21825305.
32. Cordeiro AC, Qureshi AR, Lindholm B, Amparo FC, Tito-Paladino-Filho A, Perini M, Lourenco FS, Pinto IM, Amodeo C, Carrero JJ. Visceral fat and coronary artery calcification in patients with chronic kidney disease. Nephrol Dial Transplant 2013, 28(Suppl 4):iv152-iv159. 10.1093/ndt/gft250, 23832273.
33. Oh JY, Sung YA, Lee HJ. The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity 2013, 21(8):1690-1694. 10.1002/oby.20096, 23585246.
34. Ciresi A, Amato MC, Pizzolanti G, Giordano Galluzzo C. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. J Clin Endocrinol Metab 2012, 97(8):2907-2915. 10.1210/jc.2012-1518, 22679062.
35. Mazzuca E, Battaglia S, Marrone O, Marotta AM, Castrogiovanni A, Esquinas C, Barcelo A, Barbe F, Bonsignore MR. Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea. J Sleep Res 2014, 23(1):13-21. 10.1111/jsr.12088, 24118617.
36. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000, 278(5):E941-E948. 10780952.
37. Taksali SE, Caprio S, Dziura J, Dufour S, Cali AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA, Weiss R. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 2008, 57(2):367-371. 10.2337/db07-0932, 17977954.
38. Velludo CM, Kamimura MA, Sanches FM, Lemos MM, Canziani ME, Pupim LB, Draibe SA, Cuppari L. Prospective evaluation of waist circumference and visceral adipose tissue in patients with chronic kidney disease. Am J Nephrol 2010, 31(2):104-109. 10.1159/000259896, 19923795.
39. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, Bergstrom J. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002, 13(Suppl 1):S28-S36. 11792759.
40. Huang JW, Yang CY, Wu HY, Liu KL, Su CT, Wu CK, Lee JK, Chiang CK, Cheng HT, Lien YC, Hung KY. Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients. Cardiovasc Diabetol 2013, 12:86. 10.1186/1475-2840-12-86, 23758640.